Evidence map›Paper›PMID 40696875›Full record

ReviewEuropean journal of immunology2025

Self-Antigens Select B Cells: A New Perspective on B Cell Selection and Function.

Mike Aoun, Rikard Holmdahl

Abstract readReview
In one paragraph

Review in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Special Issue: Autoimmune Diseases: A Swing Dance of Immune Cells.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mike AounDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Rikard HolmdahlDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-4969-2576

Funding

Key Research and Development Program of Shaanxi Province 2024GH-ZDXM-34Magnus Bergvalls Stiftelse 2024-1050National Natural Science Foundation of China 82471830National Natural Science Foundation of China W2431021Reumatikerförbundet R-995237Stiftelsen Konung Gustaf V:s 80-årsfond FAI-2024-1106Stiftelsen Professor Nanna Svartz Fond 2024-066Ulla och Gustaf af Ugglas Stiftelse 2024-03675
6 · The paper itself

Abstract

The adaptive immune system is shaped by self-recognition, creating a paradox where autoreactivity is essential for immune regulation, yet implicated in autoimmune diseases. Traditionally, B cell selection in the bone marrow (BM) has been viewed through the lens of negative selection, eliminating potentially harmful clones. Emerging evidence challenges this perspective, revealing a subset of B suppressor cells (Bsup) that actively regulate immune homeostasis. Unlike conventional negative selection, C1-specific Bsup cells, which recognize collagen type II (Col2), engage Col2-specific regulatory T cells (Tregs) to suppress inflammation in healthy individuals. This suggests that Bsup play a role in both peripheral and central tolerance, akin to Tregs. However, the molecular mechanisms governing Bsup selection, differentiation, and function remain unknown. Understanding how Bsup distinguish homeostatic from pathogenic autoreactivity could transform autoimmune disease treatment, shifting the focus from eliminating autoreactive B cells to harnessing their regulatory potential for precision immunotherapy.

Indexed as

AutoantigensB-LymphocytesAnimalsAutoimmune DiseasesAutoimmunityCell DifferentiationHumansImmune ToleranceT-Lymphocytes, RegulatoryAutoantigensautoimmunityB cell developmentimmune regulationinflammationself/non‐self discrimination

Identifiers

PMID40696875
PMCPMC12284462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.